This is a very aggressive type of cancer that starts in the early stages of development. It's rare, especially in the ovaries, but more common in the testes.
Every report comes from a Lived member, sent anonymously.
Have you had Orchidectomy for Embryonal Carcinoma?
Embryonal carcinoma is a type of testicular cancer that starts in germ cells, the cells that normally develop into sperm. Under a microscope its cells resemble tissue from a very early embryo, which is where the name comes from. It tends to grow quickly and can spread beyond the testicle, often first to the lymph nodes at the back of the abdomen (the retroperitoneum). Testicular germ cell cancers are divided into two broad groups for treatment: seminomas and nonseminomas. Embryonal carcinoma is one of the nonseminomas. It rarely appears on its own (pure embryonal carcinoma makes up only about 3 to 4% of testicular tumors), but embryonal carcinoma cells are found in about 40% of them, usually mixed with other germ cell types. A mixed tumor that contains embryonal carcinoma is treated as a nonseminoma. Embryonal carcinoma can also arise, rarely, in an ovary, where it is managed as an ovarian germ cell tumor; this page focuses on the testicular form.
Nonseminomas, including embryonal carcinoma, usually occur in men between their late teens and early 30s. The best-known risk factor for testicular germ cell cancer is an undescended testicle (cryptorchidism), a testicle that did not move down into the scrotum before birth. Surgery to bring the testicle down before puberty appears to lower that risk, although this is not certain. A father or brother with testicular cancer, a previous testicular cancer and abnormal testicle development also raise risk. Most men with these risk factors never develop cancer, and many men who do have none of them. Nothing a person did is known to cause embryonal carcinoma.
Most testicular cancers are first noticed as a lump, swelling or change in how a testicle feels. A clinician examines the scrotum and orders an ultrasound, which can show whether a lump is solid tissue inside the testicle. Blood tests for tumor markers are taken before any surgery. These are proteins some germ cell tumors release into the blood: alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (beta-hCG) and lactate dehydrogenase (LDH). Embryonal carcinoma can raise AFP and hCG. A raised AFP matters because pure seminoma does not make it, so it points to a nonseminoma even when a tumor otherwise looks like seminoma. LDH can rise for many reasons unrelated to cancer, so it is interpreted alongside the others. The diagnosis is confirmed by removing the whole testicle through a cut in the groin (radical inguinal orchiectomy) and examining it under a microscope. The pathology report describes which germ cell types are present, what share is embryonal carcinoma, and whether cancer cells have entered blood or lymph vessels (lymphovascular invasion). CT scans of the abdomen, pelvis and chest, together with marker levels after surgery, then establish the stage.
Removing the testicle is the first treatment as well as the diagnosis. What follows depends on the stage and, for cancer that has spread, on a risk group based on where it has spread and how high the tumor markers are. When scans and markers show no sign of spread (stage I), three approaches cure about 99% of people. Surveillance means no further treatment, with frequent checkups, blood tests and scans, and treatment only if the cancer returns. A second option is retroperitoneal lymph node dissection (RPLND), surgery to remove the lymph nodes at the back of the abdomen where this cancer usually spreads first. The third is one or two cycles of chemotherapy to lower the chance of relapse. Tumors made up mostly of embryonal carcinoma, especially with lymphovascular invasion, are more likely to come back, so many people with these features and their doctors lean toward RPLND or chemotherapy rather than surveillance alone. When the cancer has spread, treatment is usually combination chemotherapy built around cisplatin, a platinum-based cancer drug. The standard regimen, called BEP, combines bleomycin, etoposide and cisplatin, given in three-week cycles. Lymph node surgery is an option for some people with limited spread to the abdominal nodes. Any mass still visible after chemotherapy is usually removed because it often contains remaining cancer or teratoma, another germ cell type. Chemotherapy, RPLND and radiation can each affect fertility, so sperm banking is worth arranging before any treatment beyond removing the testicle. Standard RPLND can stop semen from coming out during ejaculation; a nerve-sparing technique preserves ejaculation in nearly all men with early-stage disease. Experience matters: outcomes for advanced disease appear better at centers that treat many germ cell tumors.
Embryonal carcinoma is aggressive in how fast it can grow, but it is also one of the most curable cancers. Stage I nonseminoma is cured in more than 99% of cases, and stage II in more than 95%. Most people with more widespread disease are also cured, though the outlook depends on the risk group: cancer that has spread to organs other than the lungs, or very high marker levels, carries a poorer prognosis. Follow-up is a major part of life after treatment. Visits combine physical exams, tumor marker blood tests and periodic CT scans, and become less frequent as time passes without a relapse. A rising AFP or hCG is often the earliest sign that cancer has returned, sometimes before anything shows on a scan; relapses after stage I disease are still highly curable. People on surveillance need to keep this schedule reliably, since it is what makes skipping further treatment safe. Most men can still father children after treatment, often without using stored sperm. People treated with chemotherapy have higher long-term risks of heart disease, some hearing loss at high pitches (usually not enough to affect conversation), reduced lung function and second cancers. Long-term care therefore includes attention to heart health and general wellbeing alongside cancer follow-up.
See a clinician soon about a painless lump or swelling in a testicle, a change in how a testicle feels, a dull ache in the lower belly or groin, or a sudden build-up of fluid in the scrotum. An exam and ultrasound can usually tell quickly whether a lump needs further testing. After treatment, tell the care team about any change in the remaining testicle, since a cancer in one testicle raises the risk in the other. New, persistent back pain between visits is also worth reporting rather than waiting for the next scheduled check, since the lymph nodes at the back of the abdomen are where this cancer most often returns.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Embryonal Carcinoma is like, what's helped you, or ask the community a question.